Masruroh Rahayu

Masruroh Rahayu

Auto-generated profile, based on publicly available information

Masruroh Rahayu

Department of Management, Faculty of Economics and Business, University of Brawijaya, Malang, Indonesia

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2020 in International Journal of Public Health Science (IJPHS)
Verified
Journal Article
Open access
PDF file
NHNur Hidayat
Nur Hidayat
AAAhsan Ahsan
Ahsan Ahsan
MRMasruroh Rahayu
Masruroh Rahayu
RLRetno Lestari
Retno Lestari
Response time and waiting time were key performance indicators in the emergency department of a hospital. This study will shed light on important factors contributing to service quality in emergency department of Indonesian public hospital by utilizing a cross-sectional design. About 117 patients were selected by simple random sampling techniques. Data observation sheets and a modified service quality instrument were used to measure health services in this department. Findings revealed that 83.8% patients felt satisfied with the services provided by emergency staff. Based on Kendall’s Tau test, waiting time had a significant relationship with service quality (p0.05). The results of logistic regression test showed that waiting time had a higher value for Exp(B)= 3.522. In conclusion, waiting time was the most important factor affecting service quality in emergency department of Indonesian public hospital.

1 January 2019 in Research Journal of Pharmacy and Technology
Verified
Journal Article
Open access
MHMuhammad Hamdan
Muhammad Hamdan
NANoorhamdani As
Noorhamdani As
MRMasruroh Rahayu
Masruroh Rahayu
MMMohammmad Hasan Machfoed
Mohammmad Hasan Machfoed

1 January 2019 in MNJ (Malang Neurology Journal)
Verified
Journal Article
Open access
PDF file
NRNeila Raisa
Neila Raisa
HSHidayat Sujuti
Hidayat Sujuti
HPHari Purnomo
Hari Purnomo
MRMasruroh Rahayu
Masruroh Rahayu
MDMochamad Dalhar
Mochamad Dalhar
Background: Serum Glial Fibrillary Acidic Protein (GFAP) is a great potential for biomarker that is widely studied as a diagnostic biomarker of acute stroke. Sampling within 6 hours after onset is the best time window, but in Indonesia, stroke patients often arrive late more than 6 hours. Objective: To identify the difference in time of blood sampling with serum GFAP levels within 24 hours onset of ischemic stroke (IS) patients and intracerebral hemorrhage (ICH) strokes. Methods: Cross-sectional analysis with purposive sampling, sampling in IS and ICH strokes that arrive at the ER within 24-hour on-site. The serum GFAP examination was performed with ELISA. Results: In this study, 41 acute stroke patients with 24-hour onset of each stroke were grouped into group 1 (<6 hours), group 2 (6-12 hours) and group 3 (12-24 hours). One Way ANOVA and Tukey's analysis showed no significant difference in GFAP levels among the three groups in both IS and ICH. Conclusion: There was no significant difference in GFAP levels in samples <6 hours, 6-12 hours, and 12-24 hours in ischemic strokes and ICH strokes.

1 July 2023 in MNJ (Malang Neurology Journal)
Verified
Journal Article
Open access
PDF file
RMRislan Faiz Muhammad
Rislan Faiz Muhammad
BABasya Adnani
Basya Adnani
SASafira Dita Arviana
Safira Dita Arviana
AVAldita Husna Violita
Aldita Husna Violita
HKHusnul Khotimah
Husnul Khotimah
MRMasruroh Rahayu
Masruroh Rahayu
Background: Stroke, particularly ischemic stroke, is one of the leading causes of death worldwide. Ischemic stroke causes a failure of oxidative phosphorylation and ATP synthesis, resulting in high levels of reactive oxygen species (ROS), neuroinflammatory responses, and apoptosis, all of which result in cell death. Neuroprotective agents are given to prevent the infarct area from expanding. Objective: This study aims to predict an in silico interaction by 7,8-dihydroxyflavone as neuprotective agent through TrkB signaling and inhibiting Glutaminase activity. Methods: In silico simulation with 7,8-dihydroxyflavone (DHF) as neuroprotective agent using PubChem, RCSB, Biovia Discovery Studio, PyRx, and PyMol software. This study analyzes the pharmacokinetics, pharmacodynamics, and protein-ligand interactions between 7,8-DHF as a ligand with TrkB (4AT5) and Glutaminase (5JYO) as protein target, compared to their native ligand. Results: 7,8 DHF binds to 4AT5 and 5JYO with lower bond energy (-9.4 Kcal/mol and -6.3 Kcal/mol, respectively) than the native ligand (-5 Kcal/mol and -5.9 Kcal/mol, respectively). It means that 7,8-DHF may increase protective mechanism. Conclusion: These findings tend to increase downstream signaling pathways, leading to increased TrkB expression, which induces protective mechanisms, and decreased glutamate expression, which reduces glutamate toxicity.